CausalSentinel

Protein Dossier — LGMN (Legumain)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Forced vital capacity (FVC) 0.0421 0.0121 5.13e-04 Wald ratio 1 cis NA
Forced expiratory volume in 1-second (FEV1) 0.0437 0.0128 6.40e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: retinal detachment 0.459 0.168 0.00649 Wald ratio 1 cis NA
Fractured or broken bones in last 5 years 0.104 0.0416 0.0121 Wald ratio 1 cis NA
Birth weight 0.053 0.0243 0.0289 Wald ratio 1 cis NA
Non-cancer illness code self-reported: high cholesterol -0.0915 0.0439 0.0372 Wald ratio 1 cis NA
Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0858 0.0425 0.0436 Wald ratio 1 cis NA
ER-positive Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.101 0.0507 0.0463 Wald ratio 1 cis NA
Diagnoses - main ICD10: M54 Dorsalgia -0.325 0.164 0.0477 Wald ratio 1 cis NA
Squamous cell lung cancer -0.32 0.165 0.0528 Wald ratio 1 cis NA
Sodium in urine -0.0267 0.0145 0.0662 Wald ratio 1 cis NA
Weight 0.0236 0.013 0.0709 Wald ratio 1 cis NA
…and 64 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3622_33_4 LGMN Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

55 association rows across 36 traits (53 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating LGMN levels 2e-298 rs148659834 7 GCST90860643 no MR -> candidate analysis
LGMN protein levels 2e-298 rs148659834 6 GCST90469766 no MR -> candidate analysis
LGMN/TIMP1 protein level ratio 1e-278 rs117845934 1 GCST90315325 no MR -> candidate analysis
CD164/LGMN protein level ratio 3e-262 rs117845934 1 GCST90313741 no MR -> candidate analysis
LGMN/SPINT2 protein level ratio 3e-119 rs17128502 1 GCST90315324 no MR -> candidate analysis
TMEM106A protein levels 3e-97 rs72701845 3 GCST90470886 no MR -> candidate analysis
Legumain levels 1e-43 rs7157038 4 GCST90248281 no MR -> candidate analysis
Transmembrane protein 106A levels 5e-38 rs72701845 3 GCST90249752 no MR -> candidate analysis
ASAH1 protein levels 5e-33 rs72701845 1 GCST90468373 no MR -> candidate analysis
Beta-mannosidase levels 3e-31 rs35792499 2 GCST90246709 no MR -> candidate analysis
CD164 protein levels 6e-27 rs72701845 1 GCST90468602 no MR -> candidate analysis
Legumain (analyte X3622.33) levels 4e-22 rs4904977 1 GCST90425835 no MR -> candidate analysis
…and 24 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1008 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
crush injury 0.49 common-variant locus no MR -> candidate analysis
Alzheimer disease 0.419 common-variant locus no MR -> candidate analysis
post term pregnancy 0.419 common-variant locus no MR -> candidate analysis
rosacea 0.419 common-variant locus no MR -> candidate analysis
pathological myopia 0.182 established (curated) no MR -> candidate analysis
myopia 0.182 established (curated) no MR -> candidate analysis

Of the 6 rows above, 6 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Legumain)
gnomAD constraint pLI=7.1e-08, LOEUF=0.836 — LoF-tolerant
GWAS Catalog 114 unique SNPs / 196 rows
ClinVar 135 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance